• 2008: hVIVO Year in Review: Milestones, Growth and 2025 Ambitions

  • Dec 20 2024
  • Length: 9 mins
  • Podcast

2008: hVIVO Year in Review: Milestones, Growth and 2025 Ambitions

  • Summary

  • In our recent interview with Mo Khan, CEO of hVIVO, we reflected on the company’s outstanding achievements in 2024 and gained insights into its ambitious roadmap for 2025. Under Mo’s leadership, hVIVO has solidified its position as a global leader in human challenge trials, achieving record revenues, expanding its client base, and leveraging its cutting-edge clinical trial models to accelerate drug and vaccine development.
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about 2008: hVIVO Year in Review: Milestones, Growth and 2025 Ambitions

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.